Mimicking SP-C palmitoylation on a peptoid-based SP-B analogue markedly improves surface activity

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 9, 2010, Pages 1663-1678

  Dohm, Michelle T ^a   Brown, Nathan J ^b   Seurynck Servoss, Shannon L ^b   de la Serna, Jorge Bernardino ^c   Barron, Annelise E ^b,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Stanford University   (United States)

Author keywords

Lipid bilayer; Lipid monolayer; Lung surfactant; Peptoid; SP B; SP C

Indexed keywords

CATION; LIPID; LUNG SURFACTANT; OCTADECYLAMINE; PEPTOID; SURFACTANT PROTEIN SP B; SURFACTANT PROTEIN SP C; UNCLASSIFIED DRUG; LIPID BILAYER; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ALKYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; IN VITRO STUDY; LIPID BILAYER; MEMBRANE VESICLE; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN VARIANT; SURFACE PROPERTY; ATOMIC FORCE MICROSCOPY; CHEMISTRY; CIRCULAR DICHROISM; FLUORESCENCE MICROSCOPY; LIPOYLATION; TEMPERATURE; ULTRAVIOLET SPECTROPHOTOMETRY;

CIRCULAR DICHROISM; LIPID BILAYERS; LIPOYLATION; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; SPECTROPHOTOMETRY, ULTRAVIOLET; SURFACE PROPERTIES; TEMPERATURE;

ANIMALIA; VERTEBRATA;

EID: 77954660884     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.04.012     Document Type: Article

References (86)

1. Creuwels L., van Golde L.M., Haagsman H.P. The pulmonary surfactant system: biochemical and clinical aspects. Lung 1997, 175:1-39.
2. Goerke J., Clements J.A. Alveolar surface tension and lung surfactant, The Handbook of Physiology, Sec.3, The Respiratory System. The American Physiological Society, Bethesda, MD 1986, vol. 3:247-262.
3. Notter R.H. Lung Surfactants: Basic Science and Clinical Applications 2000, Marcel Dekker, New York.
4. Serrano A.G., Perez-Gil J. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem. Phys. Lipids 2006, 141:105-118.
5. Hawgood S., Schiffer K. Structures and properties of the surfactant-associated proteins. Annu. Rev. Physiol. 1991, 53:375-394.
6. Johansson J., Curstedt T., Robertson B. The proteins of the surfactant system. Eur. Respir. J. 1994, 7:372-391.
7. Hall S.B., Venkitaraman A.R., Whitsett J.A., Holm B.A., Notter R.H. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am. Rev. Respir. Dis. 1992, 145:24-30.
8. Pérez-Gil J., Keough K.M.W. Interfacial properties of surfactant proteins. Biochim. Biophys. Acta 1998, 1408:203-217.
9. Wang Z.D., Hall S.B., Notter R.H. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant. J. Lipid Res. 1996, 37:790-798.
10. Veldhuizen R., Nag K., Orgeig S., Possmayer F. The role of lipids in pulmonary surfactant. Biochim. Biophys. Acta 1998, 1408:90-108.
11. Avery M.E., Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child. 1959, 97:517-523.
12. Pison U., Seeger W., Buchhorn R., Joka T., Brand M., Obertacke U., Neuhof H., Schmit-Nauerburg K.P. Surfactant abnormalities in patients with respiratory-failure after multiple trauma. Am. Rev. Respir. Dis. 1989, 140:1033-1039.
13. Lewis J.E., Jobe A.H. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1993, 147:218-233.
14. Robertson B., Johansson J., Curstedt T. Synthetic surfactants to treat neonatal lung disease. Mol. Med. Today 2000, 6:119-124.
15. Blanco O., Pérez-Gil J. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat respiratory distress syndrome: role of the different components in an efficient pulmonary surfactant. Eur. J. Pharmacol. 2007, 568:1-15.
16. Moya F.R., Maturana A. Animal-derived surfactants versus past and current synthetic surfactants: current status. Clin. Perinatol. 2007, 34:145-177.
17. Kirshenbaum K., Barron A.E., Goldsmith R.A., Armand P., Bradley E.K., Truong K.T.V., Dill K.A., Cohen F.E., Zuckermann R.N. Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:4303-4308.
18. Wu C.W., Seurynck S.L., Lee K.Y.C., Barron A.E. Helical peptoid mimics of lung surfactant protein C. Chem. Biol. 2003, 10:1057-1063.
19. Seurynck S.L., Patch J.A., Barron A.E. Simple, helical peptoid analogs of lung surfactant protein B. Chem. Biol. 2005, 12:77-88.
20. Seurynck-Servoss S.L., Dohm M.T., Barron A.E. Effects of including an N-terminal insertion region and arginine-mimetic side chains in helical peptoid analogues of lung surfactant protein B. Biochemistry 2006, 45:11809-11818.
21. Seurynck-Servoss S.L., Brown N.J., Dohm M.T., Wu C.W., Barron A.E. Lipid composition greatly affects the in vitro surface activity of lung surfactant protein mimics. Colloids Surf., B Biointerfaces 2007, 57:37-55.
22. Brown N.J., Wu C.W., Seurynck-Servoss S.L., Barron A.E. Effects of hydrophobic helix length and side chain chemistry on biomimicry in peptoid analogues of SP-C. Biochemistry 2008, 47:1808-1818.
23. Dohm M.T., Seurynck-Servoss S.L., Seo J., Zuckermann R.N., Barron A.E. Close mimicry of lung surfactant protein B by "clicked" dimers of helical, cationic peptoids. Biopolymers (Peptide Sci.) 2009, 92:538-553.
24. Zuckermann R.N., Kerr J.M., Kent S.B.H., Moos W.H. Efficient method for the preparation of peptoids oligo(N-substituted glycines) by submonomer solid-phase synthesis. J. Am. Chem. Soc. 1992, 114:10646-10647.
25. Sanborn T.J., Wu C.W., Zuckermann R.N., Barron A.E. Extreme stability of helices formed by water-soluble poly-N-substituted glycines (polypeptoids) with alpha-chiral side chains. Biopolymers 2002, 63:12-20.
26. Wu C.W., Sanborn T.J., Zuckermann R.N., Barron A.E. Peptoid oligomers with alpha-chiral, aromatic side chains: effects of chain length on secondary structure. J. Am. Chem. Soc. 2001, 123:2958-2963.
27. Armand P., Kirshenbaum K., Goldsmith R.A., Farr-Jones S., Barron A.E., Truong K.T.V., Dill K.A., Mierke D.F., Cohen F.E., Zuckermann R.N., Bradley E.K. NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:4309-4314.
28. Wu C.W., Kirshenbaum K., Sanborn T.J., Patch J.A., Huang K., Dill K.A., Zuckermann R.N., Barron A.E. Structural and spectroscopic studies of peptoid oligomers with alpha-chiral aliphatic side chains. J. Am. Chem. Soc. 2003, 125:13525-13530.
29. Andersson M., Curstedt T., Jornvall H., Johansson J. An amphipathic helical motif common to tumourolytic polypeptide NK-Lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett. 1995, 362:328-332.
30. Hawgood S., Derrick M., Poulain F. Structure and properties of surfactant protein B. Biochim. Biophys. Acta 1998, 1408:150-160.
31. Zaltash S., Palmblad M., Curstedt T., Johansson J., Persson B. Pulmonary surfactant protein B: a structural model and a functional analogue. Biochim. Biophys. Acta 2000, 1466:179-186.
32. Haagsman H.P., Diemel R.V. Surfactant-associated proteins: functions and structural variation. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 2001, 129:91-108.
33. Vandenbussche G., Clercx A., Clercx M., Curstedt T., Johansson J., Jornvall H., Ruysschaert J.M. Secondary structure and orientation of the surfactant protein SP-B in a lipid environment - a Fourier-transform infrared-spectroscopy study. Biochemistry 1992, 31:9169-9176.
34. Waring A., Taeusch H.W., Bruni R., Amirkhanian J.D., Fan B.R., Stevens R., Young J. Synthetic amphipathic sequences of surfactant protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins. Pept. Res. 1989, 2:308-313.
35. Bruni R., Taeusch H.W., Waring A.J. Surfactant protein-B-lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7451-7455.
36. Baatz J.E., Sarin V., Absolom D.R., Baxter C., Whitsett J.A. Effects of surfactant-associated protein SP-B synthetic analogs on the structure and surface-activity of model membrane bilayers. Chem. Phys. Lipids 1991, 60:163-178.
37. Gordon L.M., Horvath S., Longo M.L., Zasadzinski J.A.N., Taeusch H.W., Faull K., Leung C., Waring A.J. Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci. 1996, 5:1662-1675.
38. Gordon L.M., Lee K.Y.C., Lipp M.M., Zasadzinski J.A., Walther F.J., Sherman M.A., Waring A.J. Conformational mapping of the N-terminal segment of surfactant protein B in lipid using C-13-enhanced Fourier transform infrared spectroscopy. J. Pept. Res. 2000, 55:330-347.
39. Cochrane C.G., Revak S.D. Pulmonary surfactant protein-B (SP-B)-structure-function-relationships. Science 1991, 254:566-568.
40. Veldhuizen E.J.A., Waring A.J., Walther F.J., Batenburg J.J., van Golde L.M.G., Haagsman H.P. Dimeric N-terminal segment of human surfactant protein B (dSP-B1-25) has enhanced surface properties compared to monomeric SP-B1-25. Biophys. J. 2000, 79:377-384.
41. Waring A.J., Walther F., Gordon L.M., Hernandez-Juviel J., Hong T., Sherman M.A., Alonso C., Alig T., Brauner J.W., Bacon D., Zasadzinski J. The role of charged amphipathic helices in the structure and function of surfactant protein B. J. Pept. Res. 2005, 66:364-374.
42. Johansson J., Szyperski T., Curstedt T., Wuthrich K. The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich α-helix. Biochemistry 1994, 33.
43. Creuwels L.A., Boer E.H., Demel R.A., van Golde L.M.G., Haagsman H.P. Neutralization of the positive charges of surfactant protein C: effects on structure and function. J. Biol. Chem. 1995, 270:16225-16229.
44. Kramer A., Wintergalen A., Sieber M., Galla H.J., Amrein M., Guckenberger R. Distribution of the surfactant-associated protein C within a lung surfactant model film investigated by near-field optical microscopy. Biophys. J. 2000, 78:458-465.
45. Bi X.H., Flach C.R., Perez-Gil J., Plasencia I., Andreu D., Oliveira E., Mendelsohn R. Secondary structure and lipid interactions of the N-terminal segment of pulmonary surfactant SP-C in Langmuir films: IR reflection-absorption spectroscopy and surface pressure studies. Biochemistry 2002, 41:8385-8395.
46. Alonso C., Waring A., Zasadzinski J.A. Keeping lung surfactant where it belongs: protein regulation of two-dimensional viscosity. Biophys. J. 2005, 89:266-273.
47. Nakorn P.N., Meyer M.C., Flach C.R., Mendelsohn R., Galla H.J. Surfactant protein C and lung function: new insights into the role of alpha-helical length and palmitoylation. Eur. Biophys. J. 2007, 36:477-489.
48. Plasencia I., Baumgart F., Andreu D., Marsh D., Perez-Gil J. Effect of acylation on the interaction of the N-terminal segment of pulmonary surfactant protein SP-C with phospholipid membranes. Biochim. Biophys. Acta 2008, 1778:1274-1282.
49. Takei T., Hashimoto Y., Aiba T., Sakai K., Fujiwara T. The surface properties of chemically synthesized peptides analogous to human pulmonary surfactant protein C. Biol. Pharm. Bull. 1996, 19:1247-1253.
50. Ikegami M., Jobe A.H. Surfactant protein-C in ventilated premature lamb lung. Pediatr. Res. 1998, 44:860-864.
51. Nilsson G., Gustafsson M., Vandenbussche G., Veldhuizen E., Griffiths W.J., Sjovall J., Haagsman H.P., Ruysschaert J.M., Robertson B., Curstedt T., Johansson J. Synthetic peptide-containing surfactants - evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution. Eur. J. Biochem. 1998, 255:116-124.
52. Hawgood S., Ogawa A., Yukitake K., Schlueter M., Brown C., White T., Buckley D., Lesikar D., Benson B.J. Lung function in premature rabbits teated with recombinant human surfactant protein C. Am. J. Respir. Crit. Care Med. 1996, 154:484-490.
53. Lukovic D., Plasencia I., Taberner F.J., Salgado J., Calvete J.J., Perez-Gil J., Mingarro I. Production and characterisation of recombinant forms of human pulmonary surfactant protein C (SP-C): structure and surface activity. Biochim. Biophys. Acta 2006, 1758:509-518.
54. Tanaka Y., Takei T., Aiba T., Masuda K., Kiuchi A., Fujiwara T. Development of synthetic lung surfactants. J. Lipid Res. 1986, 27:475-485.
55. Brown N.J., Johansson J., Barron A.E. Biomimicry of surfactant protein C. Acc. Chem. Res. 2008, 41:1409-1417.
56. Blume A. A comparative study of the phase transitions of phospholipid bilayers and monolayers. Biochim. Biophys. Acta 1979, 557:32-44.
57. Marsh D. Lateral pressure in membranes. Biochim. Biophys. Acta 1996, 1286:183-223.
58. Perez-Gil J., Cruz A., Casals C. Solubility of hydrophobic surfactant proteins in organic solvent/water mixtures. Structural studies on SP-B and SP-C in aqueous organic solvents and lipids. Biochim. Biophys. Acta 1993, 1168:261-270.
59. Merrifield R.B. Solid phase peptide synthesis. I. the synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85:2149-2154.
60. Plasencia I., Cruz A., Lopez-Lacomba C., Flach C.R., Perez-Gil J. Selective labeling of pulmonary surfactant protein SP-C in organic solution. Anal. Biochem. 2001, 296:49-56.
61. Bringezu F., Ding J.Q., Brezesinski G., Waring A.J., Zasadzinski J.A. Influence of pulmonary surfactant protein B on model lung surfactant monolayers. Langmuir 2002, 18:2319-2325.
62. Bringezu F., Ding J.Q., Brezesinski G., Zasadzinski J.A. Changes in model lung surfactant monolayers induced by palmitic acid. Langmuir 2001, 17:4641-4648.
63. Seurynck S.L., Brown N.J., Wu C.W., Germino K.W., Kohlmeir E.K., Ingenito E.P., Glucksberg M.R., Barron A.E., Johnson M. Optical monitoring of bubble size and shape in a pulsating bubble surfactometer. J. Appl. Physiol. 2005, 99:624-633.
64. Frey S.L., Pocivavsek L., Waring A.J., Walther F.J., Hernandez-Juviel J.M., Ruchala P., Lee K.Y.C. Functional importance of the NH2-terminal insertion sequence of lung surfactant protein B. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 298:L335-L347.
65. Putz G., Goerke J., Taeusch H.W., Clements J.A. Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. J. Appl. Physiol. 1994, 76:1425-1431.
66. Bernardino de la Serna J., Pérez-Gil J., Simonsen A.C., Bagatolli L.A. Cholesterol rules: direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures. J. Biol. Chem. 2004, 279:40715-40722.
67. Angelova M.I., Soleau S., Meleard P., Faucon J.F., Bothorel P. Preparation of giant vesicles by external AC electric fields. Prog. Colloid & Polym. Sci. 1992, 89:127-131.
68. Angelova M.I., Dimitrov D.S. Liposome electroformation. Faraday Discuss. Chem. Soc. 1986, 81:303-311.
69. Fidorra M.L., Duelund L., Leidy C., Simonsen A.C., Bagatolli L.A. Absence of fluid-ordered/fluid-disordered phase coexistence in ceramide/POPC mixtures containing cholesterol. Biophys. J. 2006, 90:4437-4451.
70. Serrano A.G., Ryan M.A., Weaver T.E., Pérez-Gil J. Critical structure-function determinants within the N-terminal region of pulmonary surfactant protein B. Biophys. J. 2006, 90:238-249.
71. N.J. Brown, J. Bernardino de la Serna, A.E. Barron, N-terminal alkylation significantly improves biomimicry of a peptoid analogue of surfactant protein C, Biophys. J. in revision (2010).
72. Cruz A., Vazquez L., Velez M., Pérez-Gil J. Effect of pulmonary surfactant protein SP-B on the micro- and nanostructure of phospholipid films. Biophys. J. 2004, 86:308-320.
73. Baumgart T., Hunt G., Farkas E.F., Webb W.W., Feigenson G.W. Fluorescence probe partitioning between Lo/Ld phases in lipid membranes. Biochim. Biophys. Acta 2007, 1768:2182-2194.
74. Ding J.Q., Doudevski I., Warriner H.E., Alig T., Zasadzinski J.A. Nanostructure changes in lung surfactant monolayers induced by interactions between palmitoyloleoylphosphatidylglycerol and surfactant protein B. Langmuir 2003, 19:1539-1550.
75. Forns P., Lauer-Fields J.L., Gao S., Fields G.B. Induction of protein-like architecture by monoalkyl hydrocarbon chains. Biopolymers (Peptide Sci.) 2000, 54:531-546.
76. Fields G.B., Lauer J.L., Dori Y., Forns P., Yu Y.-C., Tirrell M. Proteinlike molecular architecture: biomaterial application for inducing cellular receptor binding and signal transduction. Biopolymers (Peptide Sci.) 1998, 47:143-151.
77. Thomas R. The denaturation of DNA. Gene 1993, 135:77-79.
78. Walters R.W., Jenq R.R., Hall S.B. Distinct steps in the adsorption of pulmonary surfactant to an air-liquid interface. Biophys. J. 2000, 78:257-266.
79. Saenz A., Canadas O., Bagatolli L.A., Johnson M.E., Casals C. Physical properties and surface activity of surfactant-like membranes containing the cationic and hydrophobic peptide KL4. FEBS J. 2006, 273:2515-2527.
80. Perez-Gil J. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim. Biophys. Acta 2008, 1778:1676-1695.
81. Zuo Y.Y., Veldhuizen R.A.W., Neumann A.W., Petersen N.O., Possmayer F. Current perspectives in pulmonary surfactant - inhibition, enhancement and evaluation. Biochim. Biophys. Acta 2008, 1778:1947-1977.
82. Avrahami D., Shai Y. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action. Biochemistry 2003, 42:14946-14956.
83. Nadolski M.J., Linder M.E. Protein lipidation. FEBS J. 2007, 274:5202-5210.
84. Chu-Kung A.F., Bozzelli K.N., Lockwood N.A., Haseman J.R., Mayo K.H., Tirrell M. Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconj. Chem. 2004, 15:530-535.
85. Mingarro I., Lukovic D., Vilar M., Pérez-Gil J. Synthetic pulmonary surfactant preparations: new developments and future trends. Curr. Med. Chem. 2008, 15:393-403.
86. Wu C.W., Barron A.E. Biomimetic lung surfactant replacements. Biomimetic Materials and Design 2002, 565-633. Marcel-Dekker, New York. A.K. Dillow (Ed.).